Latest News
Stocks Climb on Economic Optimism
Barchart - 35 minutes ago
Barchart
35 minutes ago
The S&P 500 Index ($SPX ) (SPY ) today is up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.04%. Stocks today are moderately higher, with the S&P 500 and Dow Jones Industrials posting...
Stocks Push Higher on Positive Corporate News
Barchart - 1 hour ago
Barchart
1 hour ago
The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. Stocks today are moderately higher, with the Dow Jones Industrials posting a 1-week high....
3 Things You Need to Know if You Buy Viking Therapeutics Today
Motley Fool - Mon Nov 18, 3:45AM CST
Motley Fool
Mon Nov 18, 3:45AM CST
There aren't many biotechs that are more exciting than Viking Therapeutics (NASDAQ: VKTX) right now. Thanks to its clinical-stage candidate for weight loss, there's a real chance that this competitor could see its shares soar for years.
Is It Too Late to Buy Viking Therapeutics Stock?
Motley Fool - Sun Nov 17, 6:05AM CST
Motley Fool
Sun Nov 17, 6:05AM CST
Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech that rose in prominence this year. The drugmaker's shares are up by nearly 200% since January.
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Motley Fool - Sat Nov 16, 4:30AM CST
Motley Fool
Sat Nov 16, 4:30AM CST
Mergers and acquisitions could make a comeback with Trump headed back to Washington.
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Motley Fool - Fri Nov 15, 3:05AM CST
Motley Fool
Fri Nov 15, 3:05AM CST
Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has helped its earnings and its stock soar in recent times. It consists of the company's weight loss drugs: Mounjaro, approved...
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Motley Fool - Wed Nov 13, 8:45AM CST
Motley Fool
Wed Nov 13, 8:45AM CST
Viking Therapeutics just revealed a new plan that could make waves in the weight loss industry.
Is Viking Therapeutics a Buy on the Dip?
Motley Fool - Sun Nov 10, 4:15AM CST
Motley Fool
Sun Nov 10, 4:15AM CST
Viking stock has slipped more than 20% from its peak.
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Motley Fool - Fri Nov 8, 6:10AM CST
Motley Fool
Fri Nov 8, 6:10AM CST
All signs are pointing toward its continued success.
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Motley Fool - Thu Nov 7, 9:15AM CST
Motley Fool
Thu Nov 7, 9:15AM CST
The company's latest presentation supports the idea that its lead program will make billions.
Is Viking Therepautics a Buy Now?
Motley Fool - Tue Nov 5, 3:23AM CST
Motley Fool
Tue Nov 5, 3:23AM CST
The clinical-stage drugmaker is developing an anti-obesity drug that could go on to produce record-breaking sales.
Why Viking Therapeutics Stock Plummeted After Soaring Today
Motley Fool - Mon Nov 4, 5:33PM CST
Motley Fool
Mon Nov 4, 5:33PM CST
Are we ready for the Great Obesity Drug Gold Rush of the 2020s?
Stocks Under Pressure Ahead of Tuesdayโs Election and FOMC Meeting
Barchart - Mon Nov 4, 9:05AM CST
Barchart
Mon Nov 4, 9:05AM CST
The S&P 500 Index ($SPX ) (SPY ) today is up +0.01%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up -0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.15%. Stocks today are moderately lower on long liquidation pressures ahead of the US presidential...
MarketBeat Week in Review โ 10/28 - 11/1
MarketBeat - Sat Nov 2, 6:00AM CDT
MarketBeat
Sat Nov 2, 6:00AM CDT
Stocks staged a strong rally on Friday following a steep sell-off; a weak jobs report all but guarantees a rate cut which adds to bullish sentiment
Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
MarketBeat - Thu Oct 31, 6:00AM CDT
MarketBeat
Thu Oct 31, 6:00AM CDT
Viking Therapeutics is making headway in the weight loss drug market; but even though the payoff is years away, there's still plenty of upside for investors
This High-Flying Stock Just Became a Better Buy
Motley Fool - Thu Oct 31, 4:45AM CDT
Motley Fool
Thu Oct 31, 4:45AM CDT
It might not be too late to get in on the party.
Up 285% YTD, Is It Too Late to Buy This Biotech Stock?
Barchart - Wed Oct 30, 6:56PM CDT
Barchart
Wed Oct 30, 6:56PM CDT
Viking Therapeutics is making notable advancements in obesity treatment with VK2735 and exploring strategic partnerships for its NASH program, positioning itself at the forefront of metabolic and endocrine disorder therapies
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
Motley Fool - Sun Oct 27, 9:45AM CDT
Motley Fool
Sun Oct 27, 9:45AM CDT
Novo Nordisk dominates diabetes treatment and obesity care, but one clinical-stage pharma company could be the next breakout star.
Why Viking Therapeutics Stock Soared by Nearly 21% on Thursday
Motley Fool - Thu Oct 24, 3:55PM CDT
Motley Fool
Thu Oct 24, 3:55PM CDT
The company provided clear evidence that it has plenty of resources to continue developing a potential blockbuster drug.
Health and Wellness Industry Embraces Surge in Demand for Weight Loss Drugs
Newswire.ca - Thu Oct 24, 8:17AM CDT
Newswire.ca
Thu Oct 24, 8:17AM CDT
/CNW/ -- USA News Group News Commentary โ With more than 100 million Americans struggling with obesity, and obesity rates increasing on every continent, it's...
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia)
Motley Fool - Thu Oct 24, 7:20AM CDT
Motley Fool
Thu Oct 24, 7:20AM CDT
Regardless of who wins the presidency, investors are better off focusing on top growth stocks.
Viking Therapeutics Reports Strong Q3 Results with Promising Clinical Progress
Stock Target Advisor - Thu Oct 24, 3:04AM CDT
Stock Target Advisor
Thu Oct 24, 3:04AM CDT
Viking Therapeutics Inc (VKTX), a clinical-stage biopharmaceutical company, recently reported its financial results for the third quarter ending September 30, 2024. This quarter has been pivotal for the company, highlighting substantial advancements in its clinical pipeline, financials, and strategic focus on metabolic and endocrine disorders. Before we dive in, we...
Viking Therapeutics Gives Investors Another Reason to Remain Bullish on Its Future
Motley Fool - Thu Oct 17, 7:30AM CDT
Motley Fool
Thu Oct 17, 7:30AM CDT
Viking recently announced the results of an early-stage clinical trial for VK0214.
Where Will Viking Therapeutics Be in 5 Years?
Motley Fool - Mon Oct 14, 4:32AM CDT
Motley Fool
Mon Oct 14, 4:32AM CDT
We could be witnessing the birth of a major player in the biotech industry.
Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics
Motley Fool - Sun Oct 13, 11:11AM CDT
Motley Fool
Sun Oct 13, 11:11AM CDT
It's hard to go wrong with either company, but one is more appealing.